S
Stuart Packer
Researcher at Montefiore Medical Center
Publications - 6
Citations - 264
Stuart Packer is an academic researcher from Montefiore Medical Center. The author has contributed to research in topics: Vaccination & Seroconversion. The author has an hindex of 2, co-authored 6 publications receiving 62 citations.
Papers
More filters
Journal ArticleDOI
Seroconversion rates following COVID-19 vaccination among patients with cancer.
Astha Thakkar,Jesus D. Gonzalez-Lugo,Niyati Goradia,Radhika Gali,Lauren C. Shapiro,Kith Pradhan,Shafia Rahman,So Yeon Kim,Brian Ko,R. Alejandro Sica,Noah Kornblum,Lizamarie Bachier-Rodriguez,Margaret E McCort,Sanjay Goel,Roman Perez-Soler,Stuart Packer,Joseph A. Sparano,Benjamin A. Gartrell,Della F. Makower,Y. Goldstein,Lucia Wolgast,Amit Verma,Balazs Halmos +22 more
TL;DR: In this paper, a validated antibody assay against SARS-CoV-2 spike protein was used to determine a high seroconversion rate (94%) in 200 patients with cancer in New York City that had received full dosing with one of the FDA-approved COVID-19 vaccines.
Journal ArticleDOI
P1.07-027 PD-L1 Expression Analysis in African American (AA) and Hispanic Lung Cancer Patients at a Minority-Based Academic Cancer Center
Elaine Shum,Christopher Su,C. Zhu,Rasim Gucalp,Missak Haigentz,Stuart Packer,Roman Perez-Soler,Balazs Halmos,Haiying Cheng +8 more
Journal ArticleDOI
The impact of dietary regimen compliance on outcomes for head and neck cancer patients treated with definitive radiation therapy.
Madhur Garg,Rafi Kabarriti,Amanda Bontempo,Maria Romano,Nitin Ohri,Shankar Viswanathan,Daniel Mark,Hilda Haynes,Bradley A. Schiff,Stuart Packer,Richard V. Smith,Missak Haignentz,Chandan Guha,Shalom Kalnicki +13 more
TL;DR: Analysis of nutritional factors and compliance with dietary recommendations as related to overall survival (OS) and progression free survival (PFS) in patients treated with definitive RT between 2004-2013 finds no clear relationship between these factors and survival.
Journal ArticleDOI
Decreasing Time to Initiation of Chemotherapy for Patients Electively Admitted to a Hematologic Malignancy Service.
TL;DR: By implementing new admission workflows, optimizing the use of the electronic medical record to communicate among providers, and improving preadmission planning the authors were able to reduce the median time to chemotherapy for elective admissions by 53.2%.
Posted ContentDOI
Seroconversion rates following COVID-19 vaccination amongst patients with malignant disease- the impact of diagnosis and cancer-directed therapies
Astha Thakkar,Jesus Gonzalez Lugo,Niyati Goradia,Radhika Gali,Lauren C. Shapiro,Kith Pradhan,Shafia Rahman,So Yeon Kim,Brian Ko,R. Alejandro Sica,Noah Kornblum,Lizamarie Bachier-Rodriguez,Margaret E McCort,Sanjay Goel,Roman Perez-Soler,Stuart Packer,Joseph A. Sparano,Benjamin A. Gartrell,Della F. Makower,Y. Goldstein,Lucia Wolgast,Amit Verma,Balazs Halmos +22 more
TL;DR: In this article, the immunogenicity of COVID-19 vaccination in a cohort of cancer patients that had received full dosing with one of the FDA-approved CoV-19 vaccines was determined.